Module | Content | Database(s) |
---|---|---|
Overview | Growth of healthcare spending; Debt; Ethics | |
Medicare | 1965 legislation; Eligibility and covered population; Part A-D + payment structures; Covered services; Pricing (DRGs, Part B/Average Sales Price); Financing & the future | |
Medicaid | 1965 legislation; Eligibility and covered population; State-federal partnership; Covered services; Pricing (340B); Financing; Issues (state + physician participation, expansion); CHIP; Continuing political discussions; Dual eligibles; Medicaid Rebate Program | |
Private Insurance | Evolution of employer-based insurance |
|
Other Public Programs | Introduction to Veteran?s Health Admin |
|
Module | Content | Database(s) |
---|---|---|
Pharma & FDA | Clinical trials process; Pricing; Off-label promotion; Patents; Brand vs. generic; R&D economics |
|
FDA | Kefauver amendment; Approval process; Post-approval regulation; |
|
Providers, Hospitals, Pharmacy | Hospitals; ER costs; Safety nets; Group purchasing orgs; Specialty pharmacy providers; Institutional payers; Integrated delivery networks/health systems (Kaiser, Geisinger) | |
Private & Public Payers | Private insurance coverage; Reimbursement; Clinical policy; Types of plans (HMO, PPO, point of service, high deductible health plans); P&T committee/formulary decisions | |
Nat?l Agencies | European (NICE, IQWIG, EMA, HAS); Other bodies (AHRQ) |
|
Module | Content | Database(s) |
---|---|---|
Quality of Care | Pay for Performance; Racial/ethnic/socioeconomic disparities in outcomes |
|
Economics | Drivers of spending growth; Ways of slowing growth; Moral hazard; |
|
Evaluating Systems | Cost-effectiveness (ICER, QALY), budget impact, health outcomes (mortality, chronic disease incidence) | |
Types of Systems | Beveridge (U.K.); Bismark (Germany); National Health Insurance (Canada/Taiwan/S.Korea); Out of pocket (developing nations); Mix (U.S.) |
|
Module | Content | Database(s) |
---|---|---|
ACA | Individual mandate; Employer mandate; Marketplaces; Subsidies; Medicaid expansion; Financing; Insurance reform; Delivery innovation (ACOs, bundled payments); SCOTUS |
|
Cost Control | Payment model reform, clinical policies, care pathways, high-cost drugs + patients, billing variability; Specialists vs. PCP | |
Gaps in Care | Social determinants of health; Uninsured; Underinsured; Language access; Minority health; Trends in public health (obesity, cancer, chronic disease) | |
Healthcare Technology | Electronic health records; Rise of medical devices + apps |
|
Mortality | End of life care costs; Advanced directives; Assisted suicide; Long term care services; Nursing homes |
|
Politics | Party positions; Ethics & healthcare rights (stem cell research, abortion, privacy) |
|